cloudy.png
Friday August 7th, 2020 2:59PM

Merck ups outlook, turns profit during global vaccine hunt

By The Associated Press
Related Articles
  Contact Editor

FAIRLESS HILLS, PA (AP) — Surging sales of cancer medicines and reduced spending across the board helped Merck overcome a big hit from the coronavirus pandemic and pushed second quarter profits up by 12%.

The drugmaker blew past Wall Street projections and boosted its financial forecast for the year Friday even as it spends heavily on the development of two experimental vaccines and a possible treatment for COVID-19.

"Customer access to care is improving," said CEO Kenneth Frazier, adding that he is optimistic about vaccines and a treatment for COVID-19.

Unlike many rivals developing vaccines that will require two doses, Merck is aiming for one-dose vaccines.

The company bought Austrian vaccine maker Themis Biosciences this year to gain rights to its experimental COVID-19 vaccine. Human tests should begin this quarter. Human testing on a second type of vaccine, being developed with an international nonprofit vaccine consortium, is expected to begin this year. The latter uses the technology that’s the basis for Merck’s approved vaccine against the Ebola virus, which could improve chances for success against COVID-19.

Merck intends to try to get both approved, rather than picking the best one, because it expects multiple vaccines will be needed to protect different patient groups, research head Roger Perlmutter said Friday.

The company already has secured capacity to manufacture many millions of doses of the vaccine before the end of 2020, Frazier said. He said Merck is committed to “affordable and equitable access” to its treatments and vaccines.

In addition, Merck and partner Ridgeback Bio are developing a coronavirus treatment that was well tolerated by patients in early studies. In September, they plan to start two large trials that could lead to approval, with one for patients hospitalized with the virus and another for those being treated as outpatients.

“I am optimistic that we will be able to reduce the impact of this devastating pandemic,” Perlmutter said.

While it pursues treatments, COVID-19 is hurting Merck. The company said Friday that people are postponing visits to both doctors and veterinarians. Merck makes drugs for both people and animals.

Revenue fell 8%, to $10.87 billion, from $11.76 billion.

However, sales of immuno-oncology blockbuster Keytruda and other cancer drugs rose, partly due to approvals for new uses or patient groups.

Net income reached $3.0 billion, or $1.18 per share, up from $2.67 million, or $1.03 per share, a year earlier.

Adjusted for one-time items, income was $3.48 billion, or $1.37 per share.

Analysts surveyed by FactSet were expecting adjusted earnings of $1.06 per share and sales of $10.4 billion.

The Kenilworth, New Jersey, company said it now expects annual revenue of between $47.2 billion and $48.7 billion, and adjusted per-share earnings between $5.63 and $5.78. That’s up from its April forecast of between $46.1 billion and $48.1 billion in revenue and earnings per share of $5.17 to $5.37.

Sales of prescription medicines dropped 7%, to $9.68 billion. Nearly all of Merck's key drugs suffered sales declines, particularly those administered in hospitals and pediatric vaccines administered in doctors' offices. Sales of medicines for pets and livestock dipped 2%, to $1.1 billion, partly due to restaurant closures cutting demand for protein.

Keytruda continued its impressive growth toward potentially becoming the world’s top-selling medicine, with revenue soaring 29% in the quarter, to $3.39 billion. Revenue also jumped for Lynparza and Lenvima, two cancer drugs it sells with partner AstraZeneca.

“Despite the challenges, Merck is executing well,” with its new guidance now slightly above its 2020 financial forecast issued before the pandemic, Edward Jones analyst Ashtyn Evans wrote. She noted that sales were reduced by $1.6 billion, “as demand for doctor-administered drugs and vaccines declined and there were fewer new diagnoses.”

Merck & Co. shares rose 1% to $79.80 in midday trading Friday.

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2020 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Sleeping lions, terrible pain: A new world without tourism
A new world without mass tourism is seeing lions sleep undisturbed in South Africa, quiet at the Louvre but agonizing pain and worry for millions around the world who depend on the global industry shattered by the coronavirus
7:52AM ( 13 minutes ago )
Merck ups outlook, turns profit during global vaccine hunt
Surging sales of cancer medicines and reduced spending helped Merck overcome a big hit from the coronavirus pandemic and increase its profit 12% in the second quarter
7:52AM ( 14 minutes ago )
Fiat Chrysler posts smaller-than-expected loss despite virus
Fiat Chrysler posted a smaller-than-expected second-quarter net loss even though coronavirus-related factory closures were a huge drain on its earnings
7:47AM ( 19 minutes ago )
Associated Press (AP)
S. Korean tries washing money over virus fears, suffers loss
Money laundering is not a good idea, as a South Korean found out when he or she put banknotes in a washing machine to remove possible traces of the coronavirus
6:10AM ( 1 hour ago )
The Latest: Tokyo struggles with virus surge; cases hit 463
Japanese leaders are grappling with how to contain flareups in coronavirus cases while trying to avoid shutdowns that might push the economy deeper into recession
6:08AM ( 1 hour ago )
'Building bridges': How Bass became a leading VP contender
California congresswoman Karen Bass has emerged as a leading contender to be Democrats' vice presidential candidate
6:01AM ( 2 hours ago )
AP Business
Asian shares fall as data, earnings show pandemic fallout
Shares are mostly lower in Asia as data and corporate earnings capture dismal portrayals of the coronavirus pandemic's impact on world economies
3:38AM ( 4 hours ago )
The Latest: South Africa's cases inch close to half-million
South Africa’s number of confirmed coronavirus cases is edging close to a half-million, with the Health Ministry reporting 11,046 new cases overnight
2:47AM ( 5 hours ago )
Asian benchmarks tumble, looking to earnings, central banks
Asian shares are tumbling as earnings coming in around the world showed mostly dismal results amid the coronavirus pandemic
12:16AM ( 7 hours ago )
AP Business - Corporate News
India's Bihar state fights twin threat of virus and floods
Monsoon floods have swamped large parts of India’s densely populated Bihar state and displaced more than 300,000 people, exacerbating the risk of coronavirus and stymieing its response to the pandemic
4:42AM ( 3 hours ago )
Wall Street slips, but tech strength helps it pare losses
Most of Wall Street is pulling lower on Thursday, but the indefatigable rise for big tech stocks is helping the market trim its losses
3:20PM ( 16 hours ago )
Wall Street slips, but relentless rise for tech pares losses
Most of Wall Street is pulling lower on Thursday, but the indefatigable rise for big tech stocks is helping the market trim its losses
1:22PM ( 18 hours ago )
AP Business - Industries
Global markets sink after Fed virus warning
Global stock markets have sunk after the U.S. Federal Reserve warned the coronavirus pandemic may threaten the fragile economic recovery
5:23AM ( 1 day ago )
Asian stocks gain after Fed keep US interest rates low
Asian stock markets have risen after the U.S. Federal Reserve left interest rates unchanged to support a struggling economy
1:24AM ( 1 day ago )
Wall Street rallies as Fed keeps rates pinned at record low
Wall Street rallied on Wednesday, and the S&P 500 climbed 1.2% for its best day in two weeks after the Federal Reserve kept the accelerator floored on its support for the economy
4:45PM ( 1 day ago )
AP Business - Health Care
Sleeping lions, terrible pain: A new world without tourism
A new world without mass tourism is seeing lions sleep undisturbed in South Africa, quiet at the Louvre but agonizing pain and worry for millions around the world who depend on the global industry shattered by the coronavirus
7:52AM ( 14 minutes ago )
Fiat Chrysler posts smaller-than-expected loss despite virus
Fiat Chrysler posted a smaller-than-expected second-quarter net loss even though coronavirus-related factory closures were a huge drain on its earnings
7:47AM ( 19 minutes ago )
UK puts lockdown-easing on hold as virus spread accelerates
British Prime Minister Boris Johnson says he is postponing some planned measures to ease the lockdown because the number of new coronavirus cases in the country is on the rise
7:43AM ( 23 minutes ago )
Kremlin sternly urges Belarus to free detained Russians
The Kremlin is demanding that Belarus quickly release 33 Russian private security contractors detained on terrorism charges
7:32AM ( 34 minutes ago )
The Latest: Britain reverses, fans no longer going to sports
Britain has reversed course and now says spectators will not be able to attend sporting events in England because the coronavirus infection rate is rising
7:28AM ( 38 minutes ago )